2022

1. Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma

   Frontiers in Immunology, Vol. 13

2. Erratum: Physiological lentiviral vectors for the generation of improved CAR-T cells (Molecular Therapy - Oncolytics (2022) 25 (335–349), (S2372770522000687), (10.1016/j.omto.2022.05.003))

   Molecular Therapy - Oncolytics

3. Physiological lentiviral vectors for the generation of improved CAR-T cells

   Molecular Therapy - Oncolytics, Vol. 25, pp. 335-349